These novel pharmacological strategies, such as tirzepatide, were initially developed to address glycemic management, but significantly impact weight, metabolic status and cardiovascular outcomes
Lastly, we tested whether cells that were functionally deficient in mitochondrial ETC metabolism, owing to mutations in CI and CIV, were differentially sensitive to 5FU treatment
Wong CK, McLean BA, Baggio LL, Koehler JA, Hammoud R, Rittig N, et al
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers
Tirzepatide Once Weekly for the Treatment of Obesity AMG 133 is a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule
9.Wadden TA, Bailey TS, Billings LK, et al